| scholarly article | Q13442814 |
| P356 | DOI | 10.1006/GYNO.1995.1265 |
| P698 | PubMed publication ID | 7557613 |
| P2093 | author name string | Morris M | |
| Smith TL | |||
| Burke TW | |||
| Eifel PJ | |||
| P433 | issue | 1 | |
| P921 | main subject | adenocarcinoma | Q356033 |
| P304 | page(s) | 38-44 | |
| P577 | publication date | 1995-10-01 | |
| P1433 | published in | Gynecologic Oncology | Q5625182 |
| P1476 | title | Adenocarcinoma as an independent risk factor for disease recurrence in patients with stage IB cervical carcinoma | |
| P478 | volume | 59 |
| Q43196006 | (18)F-FDG PET in stage IB/IIB cervical adenocarcinoma/adenosquamous carcinoma |
| Q36132910 | A Nation-Wide Cancer Registry-Based Study of Adenosquamous Carcinoma in Taiwan |
| Q42480962 | A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA. |
| Q48312361 | A comparison of the prognosis between adenocarcinoma and squamous cell carcinoma in stage IB-IIA cervical cancer |
| Q43482203 | Adenocarcinoma of the cervix uteri: a retrospective study of 83 cases |
| Q38364617 | Adenocarcinoma of the cervix: should we treat it differently? |
| Q74774067 | Adenocarcinoma of the uterine cervix metastatic to lymph nodes |
| Q38261137 | Adenocarcinoma of the uterine cervix: why is it different? |
| Q37625473 | Adenocarcinoma: a unique cervical cancer |
| Q81249176 | Adenosquamous carcinoma versus adenocarcinoma in early-stage cervical cancer patients undergoing radical hysterectomy: an outcomes analysis |
| Q35113827 | Adenosquamous histology predicts a poor outcome for patients with advanced-stage, but not early-stage, cervical carcinoma |
| Q40542939 | Adenosquamous histology predicts poor outcome in low-risk stage IB1 cervical adenocarcinoma. |
| Q39614458 | Adjuvant radiochemotherapy in patients with locally advanced high-risk cervical cancer |
| Q78362447 | Age-specific differences in treatment and survival of patients with cervical cancer in the southeast of The Netherlands, 1986-1996 |
| Q39029873 | Analysis of HGF, MACC1, C-met and apoptosis-related genes in cervical carcinoma mice |
| Q41435612 | Apoptosis Phenomena in Squamous Cell Carcinomas and Adenocarcinomas of the Uterine Cervix |
| Q38702843 | Bioinformatics and in vitro experimental analyses identify the selective therapeutic potential of interferon gamma and apigenin against cervical squamous cell carcinoma and adenocarcinoma |
| Q37943650 | Cervical adenocarcinoma: moving towards better prevention |
| Q45994931 | Cervical cancer histology and tumor differentiation affect 18F-fluorodeoxyglucose uptake. |
| Q55073076 | Cervical cancer: is the wall crumbling? |
| Q33680243 | Clinical potential of bevacizumab in the treatment of metastatic and locally advanced cervical cancer: current evidence |
| Q44827354 | Comparison of adenocarcinoma (ACA) and squamous cell carcinoma (SCC) of the uterine cervix in a sub-optimally screened cohort: a population-based epidemiologic study of 51,842 women in Brazil |
| Q46116593 | Comparison of adenocarcinoma and adenosquamous carcinoma in patients with early-stage cervical cancer after radical surgery |
| Q33733792 | Comparison of outcomes between squamous cell carcinoma and adenocarcinoma in patients with surgically treated stage I-II cervical cancer |
| Q37562596 | Comparison of the outcome between cervical adenocarcinoma and squamous cell carcinoma patients with adjuvant radiotherapy following radical surgery: SGSG/TGCU Intergroup Surveillance |
| Q83368051 | Comparison of treatment outcomes between squamous cell carcinoma and adenocarcinoma in locally advanced cervical cancer |
| Q48010825 | Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1). |
| Q77380327 | Does histology influence prognosis in patients with early-stage cervical carcinoma? |
| Q84579332 | Early adenocarcinoma of the cervix: is radical vaginal trachelectomy safe? |
| Q42597487 | Early-stage node negative cervical adenocarcinoma and squamous cell carcinoma show similar survival outcomes after hysterectomy: a population-based study. |
| Q21261267 | Estimate of the global burden of cervical adenocarcinoma and potential impact of prophylactic human papillomavirus vaccination |
| Q58737479 | Estrogen/GPR30 Signaling Contributes to the Malignant Potentials of ER-Negative Cervical Adenocarcinoma via Regulation of Claudin-1 Expression |
| Q38711498 | Fertility-Sparing Options in Young Women with Cervical Cancer. |
| Q36516098 | Fertility-preserving surgery in patients with early stage cervical carcinoma |
| Q35687003 | FoxP3(+) and IL-17(+) cells are correlated with improved prognosis in cervical adenocarcinoma |
| Q37697062 | Genome-wide methylome analysis using MethylCap-seq uncovers 4 hypermethylated markers with high sensitivity for both adeno- and squamous-cell cervical carcinoma |
| Q38185849 | Glassy cell carcinoma of the cervix: a systematic review and meta-analysis |
| Q92802555 | HPV-negative Tumors in a Swedish Cohort of Cervical Cancer |
| Q90447496 | High-dose-rate intracavitary brachytherapy for recurrent cervical cancer in the vaginal stump after hysterectomy |
| Q35577975 | Imaging in cervical cancer |
| Q37648087 | Increasing incidence of invasive and in situ cervical adenocarcinoma in the Netherlands during 2004-2013. |
| Q58559220 | Indocyanine green can stand alone in detecting sentinel lymph nodes in cervical cancer |
| Q37507375 | Intermediate-risk grouping of cervical cancer patients treated with radical hysterectomy: a Korean Gynecologic Oncology Group study |
| Q46944814 | Intraarterial cisplatin/nedaplatin and intravenous 5-fluorouracil with concurrent radiation therapy for patients with high-risk uterine cervical cancer |
| Q73948308 | Invasive adenocarcinoma of the uterine cervix: MR imaging |
| Q38433490 | Inverse correlation between RASSF1A hypermethylation, KRAS and BRAF mutations in cervical adenocarcinoma |
| Q34990478 | Is human papillomavirus genotype an influencing factor on radiotherapy outcome? Ambiguity caused by an association of HPV 18 genotype and adenocarcinoma histology |
| Q40861375 | Loss of heterozygosity in clinical stage IB cervical carcinoma: relationship with clinical and histopathologic features |
| Q42124080 | Multivariate prognostic analysis of adenocarcinoma of the uterine cervix treated with radical hysterectomy and systematic lymphadenectomy. |
| Q59340808 | Neo-adjuvant treatment of adenocarcinoma and squamous cell carcinoma of the cervix results in significantly different pathological complete response rates |
| Q50788653 | Neoadjuvant chemotherapy with docetaxel and carboplatin followed by radical hysterectomy for stage IB2, IIA2, and IIB patients with non-squamous cell carcinoma of the uterine cervix. |
| Q37678092 | Oncogenic mutations in cervical cancer: genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix |
| Q91726630 | Optimal treatments for cervical adenocarcinoma |
| Q33906077 | Outcomes after radical hysterectomy in patients with early-stage adenocarcinoma of uterine cervix |
| Q84461277 | Outcomes of planned delivery delay in pregnant patients with invasive gynecologic cancer |
| Q33405384 | Phase II trial on neoadjuvant intravenous and trans-uterine arterial chemotherapy for locally advanced bulky cervical adenocarcinoma |
| Q51738130 | Postoperative clinicopathological factors affecting cervical adenocarcinoma: Stages I-IIB. |
| Q24241058 | Primary surgery versus primary radiation therapy with or without chemotherapy for early adenocarcinoma of the uterine cervix |
| Q24201754 | Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix |
| Q26774168 | Profile of bevacizumab and its potential in the treatment of cervical cancer |
| Q37450623 | Prognostic factors associated with radiotherapy for cervical cancer with computed tomography-detected para-aortic lymph node metastasis |
| Q80156611 | Prognostic factors in pathologic parametrium-positive patients with stage IB-IIB cervical cancer treated by radical surgery and adjuvant therapy |
| Q40836380 | Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy |
| Q35345467 | Prognostic implication of human papillomavirus types and species in cervical cancer patients undergoing primary treatment. |
| Q33295075 | Prognostic value of histopathology and trends in cervical cancer: a SEER population study |
| Q37222658 | Radical hysterectomy for FIGO stage I-IIB adenocarcinoma of the uterine cervix. |
| Q33563936 | Randomized study between radical surgery and radiotherapy for the treatment of stage IB-IIA cervical cancer: 20-year update |
| Q40773942 | Response of adenocarcinoma of the uterine cervix to chemoradiotherapy |
| Q53446581 | Satellite lymphovascular space invasion: An independent risk factor in early stage cervical cancer. |
| Q27027042 | State of the science in cervical cancer: where we are today and where we need to go |
| Q84464552 | The poorer survival of patients with cervical adenocarcinoma and adenosquamous cell carcinoma compared to those with squamous cell carcinoma might be improved by a different treatment |
| Q44196765 | Total laparoscopic radical trachelectomy in the treatment of early squamous cell cervical cancer: a retrospective study with 8-year follow-up |
| Q35037329 | Traditional management of invasive cervical cancer |
| Q100464649 | Transcriptome analysis uncovers the diagnostic value of miR-192-5p/HNF1A-AS1/VIL1 panel in cervical adenocarcinoma |
| Q35091194 | Treatment results of high-dose-rate remote afterloading brachytherapy for cervical cancer and retrospective comparison of two regimens |
| Q35742202 | Tumor size and lymph node status determined by imaging are reliable factors for predicting advanced cervical cancer prognosis |
| Q35185215 | Ultra-early predictive assay for treatment failure using functional magnetic resonance imaging and clinical prognostic parameters in cervical cancer. |
| Q40886667 | Vaginal Radical Trachelectomy for early stage cervical cancer. Results of the Danish National Single Center Strategy. |
Search more.